川木通的资源分布与商品初步调查  

Resource Distribution and Commercial Primary Investigation of Caulis Clematidis Armandii

作　　者：国锦琳[1] 万德光[1] 唐远[1] 裴瑾[1] 

机构地区：[1]成都中医药大学药学院,四川成都610075

出　　处：《成都中医药大学学报》2007年第1期44-46,共3页Journal of Chengdu University of Traditional Chinese Medicine

基　　金：国家自然科学基金(No.30472149)

摘　　要：目的:对四川地区川木通的植物资源进行了标本查阅与实地调查;对道地产区四川进行了有效的区划。同时对国内使用川木通的主要地区进行了商品调查,经过综合分析与鉴定,发现目前四川产川木通的野生种质资源经过多年的采伐,破坏严重,有必要进行引导合理开发并在适宜区内开展人工种植,解决该种药材的可持续性发展。对国内主要药材市场初步调查发现目前川木通商品主流品种为药典收载品种小木通(Clematis.armandii Franch.)但在商品药材中还混杂有较大量的粗齿铁线莲(C.argentilucida W.T.Wang),药典收载品种绣球藤(C.Montana Buch.-Ham.)在此次商品药材调查中未见。基于粗齿铁线莲在市场较大量的出现,《中国药典》未收载而该种本草曾有记载,有必要对其进行深入探究,澄清。Based on the literature, on -the -spot plant sample collection and commercial investigation about Caulis Clematidis Armandii, we found that wild plant resource of Caulis Clematidis Armandii was seriously destroyed. To resolve sustainable development of this Chinese medicine, we need to lead people exploitation reasonable and organize people to grow the resource in aptly area. At the same time we found that Clematis armandii Franch. and C. argentilucida W. T. Wang were the mainly commodity of Caulis Clematidis Armandii, but C. argentibucida W. T. Wang wasnt statement in Chinese Pharmacopoeia （2005ed） . C. montana Buch. - Ham didn＇s found in commodity though it was statement in Chinese Pharmacopoeia （2005ed） . Owing to C. argentilucida W. T. Wang was described in Zhiwumingshitukao （植物名实图考 Materia Medica in Qing dynasty） and the mainly commodity of Caulis Clematidis Armandii, we have to do deep research about this resource and clarify this medicine material.

关 键 词：川木通 资源分布 商品调查 

分 类 号：R282.71[医药卫生—中药学] R931.7[医药卫生—中医学]